Background: Hepatitis E virus (HEV), an RNA virus, poses a significant global health threat, affecting 2.3 billion people annually, causing 70,000 deaths, over 50% of acute viral hepatitis cases. In Pakistan, HEV prevalence is high among pregnant women (26%), with a mortality rate of 26 to 30%. Blood transmission is a leading source of sporadic HEV infection.
Methodology: The blood specimens were investigated with HEV to detect anti- IgM and IgG antibodies. Anti HEV IgM positive specimens confirmed the incidence of viral RNA by Polymerase chain reactions. The positive cases containing viral RNA were subjected to sequencing of ORF2.
Result: A total of 3480 blood specimens were screened serologically by ELISA for the existence of anti HEV IgM and anti-HEV IgG antibodies. Of these 3480 samples, 170 (4.9%) were confirmed positive when screened for HEV antibodies among study population, there was a statistically significant difference observed between males and females (p=0.00001). From 170 positive samples, 60 (1.72 %) were positive for having anti-HEV IgM antibodies in plasma, whereas 110 (3.16 %) were found with anti-HEV IgG antibodies. Among 60 (1.72 %) IgM-positive samples, 18 (0.51 %) were confirmed positive by PCR for the presence of HEV-RNA. Genotype 1 was observed in all 18 HEV RNA-positive samples.
Conclusion: The findings of this study underscore the urgency of implementing HEV screening protocols before blood donation. The risk of transmission through blood products is evident, with 4.9% of screened blood specimens exhibiting HEV antibodies. Therefore, the National Blood Transfusion Regulatory Authority must incorporate HEV screening as a routine procedure in Pakistan.